NovoRapid injection FlexPen, from Novo Nordisk Pharma, contains Insulin aspart (recombinant) and is a rapid-acting insulin used to treat diabetes mellitus in adults and children. It is administered subcutaneously, has a YJ code of 2492415G1031, and a standard of 300 units per kit.
NovoRapid injection FlexPen
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).